Bohannon N J
Geriatrics. 1996 Apr;51(4):33-7.
Several new oral drugs have been approved for the management of type II diabetes. Metformin is an "antihyperglycemic agent" that decreases hepatic glucose production and improves insulin sensitivity. It may be used as monotherapy or in combination with a sulfonylurea. Acarbose slows carbohydrate absorption after a meal, giving endogenous or injected insulin more time to respond to ingested glucose. Glimepiride is an insulin-sparing sulfonylurea with a once-daily dosing schedule. How might these medications fit into the primary care of older diabetics?
几种新型口服药物已被批准用于治疗2型糖尿病。二甲双胍是一种“抗高血糖药物”,可减少肝脏葡萄糖生成并提高胰岛素敏感性。它可以作为单一疗法使用,也可与磺脲类药物联合使用。阿卡波糖可减缓餐后碳水化合物的吸收,使内源性或注射胰岛素有更多时间对摄入的葡萄糖做出反应。格列美脲是一种胰岛素增效磺脲类药物,给药方案为每日一次。这些药物如何适用于老年糖尿病患者的初级保健?